Related Experiment Video
Updated: May 12, 2026
09:06
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
Targeted therapies through microRNAs: pulp or fiction?
Therapeutic Advances in Hematology
|April 5, 2013
Summary
MicroRNAs (miRNAs) offer targeted therapy potential for diseases. This review covers progress in miRNA delivery methods and therapeutic applications, addressing challenges for clinical use.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Post-transcriptional gene silencing mechanisms have opened avenues for targeted therapies.
- MicroRNAs (miRNAs) are key regulators of gene expression implicated in numerous diseases.
- The therapeutic potential of miRNAs has been recognized, but significant challenges remain.
Purpose of the Study:
- To review recent advancements in miRNA delivery systems.
- To discuss current and emerging applications of miRNAs as therapeutic agents.
- To highlight challenges and future directions in miRNA-based therapeutics.
Main Methods:
- Literature review of recent studies on miRNA delivery and therapeutic applications.
- Analysis of current research on miRNA biogenesis and function in disease.
- Synthesis of information on preclinical and clinical investigations of miRNA therapies.
Main Results:
- Significant progress has been made in developing novel delivery vehicles for miRNAs.
- Various miRNA-based therapeutic strategies are under investigation for diverse diseases.
- Key hurdles include achieving efficient and specific delivery, and managing potential off-target effects.
Conclusions:
- MicroRNA-based therapies hold great promise for treating a wide range of diseases.
- Overcoming delivery challenges is crucial for the successful clinical translation of miRNA therapeutics.
- Continued research is needed to optimize miRNA delivery and ensure therapeutic safety and efficacy.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...